Victory Capital Management
CSTL icon

Victory Capital Management’s Castle Biosciences CSTL Stock Holding History

Victory Capital Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,637
Closed -$669K – 2614
2022
Q3 		$669K Sell
25,637
-782
-3% -$21.9K ﹤0.01% 1918
2022
Q2 		$580K Buy
26,419
+93
+0.4% +$2.16K ﹤0.01% 1980
2022
Q1 		$588K Sell
26,326
-4,188
-14% -$173K ﹤0.01% 2062
2021
Q4 		$1.31M Sell
30,514
-289,145
-90% -$15.1M ﹤0.01% 1710
2021
Q3 		$21.3M Buy
319,659
+11,402
+4% +$802K 0.02% 872
2021
Q2 		$22.6M Sell
308,257
-78,528
-20% -$5.19M 0.02% 859
2021
Q1 		$26.5M Buy
386,785
+26,918
+7% +$2.02M 0.03% 798
2020
Q4 		$24.2M Buy
359,867
+340,767
+1,784% +$18.5M 0.03% 799
2020
Q3 		$983K Sell
19,100
-3,793
-17% -$169K ﹤0.01% 1710
2020
Q2 		$863K Sell
22,893
-22,089
-49% -$755K ﹤0.01% 1800
2020
Q1 		$1.34M Buy
44,982
+42,982
+2,149% +$1.3M ﹤0.01% 1748
2019
Q4 		$69K Sell
2,000
-702
-26% -$17.2K ﹤0.01% 2595
2019
Q3 		$49K Buy
+2,702
New +$59.9K ﹤0.01% 2691

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management's CSTL Position: Q4 2022 in Review

Victory Capital Management sold out of Castle Biosciences (CSTL) in Q4 2022, closing a stake of 25,637 shares — an estimated $669K sold.

Victory Capital Management first reported a position in CSTL in Q3 2019 and held it in 13 quarters. The position peaked at $26.5M in Q1 2021. 153 funds tracked by Wall St. Rank hold CSTL as of Q4 2022.

  • Victory Capital Management reported no remaining Castle Biosciences position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 25,637 Castle Biosciences shares in Q4 2022, an estimated $669K.
  • Victory Capital Management first reported a position in Castle Biosciences in Q3 2019 and held it in 13 quarters.
  • Victory Capital Management's Castle Biosciences position peaked at $26.5M in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.